Cargando…

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients

INTRODUCTION: Long-term inappropriate proton pump inhibitors use (PPIs) is a matter of concern because of the risks associated with their long-term use in older patients with chronic conditions. The risk of PPI treatment in hemodialysis patients remains unexplored. METHODS: We assessed the relations...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Francisco, Angel L.M., Varas, Javier, Ramos, Rosa, Merello, Jose Ignacio, Canaud, Bernard, Stuard, Stefano, Pascual, Julio, Aljama, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932134/ https://www.ncbi.nlm.nih.gov/pubmed/29725641 http://dx.doi.org/10.1016/j.ekir.2017.11.001

Ejemplares similares

The Authors Reply
por: Ramos, Rosa, et al.
Publicado: (2019)

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
por: Luño, José, et al.
Publicado: (2017)

Serum Uric Acid and Mortality Risk Among Hemodialysis Patients
por: Zawada, Adam M., et al.
Publicado: (2020)

Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine
por: Canaud, Bernard, et al.
Publicado: (2021)

Assessment of a serum calcification propensity test for the prediction of all-cause mortality among hemodialysis patients
por: Zawada, Adam M, et al.
Publicado: (2023)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

Sodium, volume and pressure control in haemodialysis patients for improved cardiovascular outcomes
por: Pinter, Jule, et al.
Publicado: (2020)

Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population
por: Hecking, Manfred, et al.
Publicado: (2018)

Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients
por: Barbieri, Carlo, et al.
Publicado: (2016)

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
por: Shah, Nigam H., et al.
Publicado: (2015)

Ultrapure Dialysis Fluid: A New Standard for Contemporary Hemodialysis
por: Canaud, Bernard, et al.
Publicado: (2012)

Predicting mortality in hemodialysis patients using machine learning analysis
por: Garcia-Montemayor, Victoria, et al.
Publicado: (2020)

Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2019)

Predialysis Hyponatremia and Positive Change of Natremia Within Hemodialysis Sessions Are Strong Indicators of Poor Cardiovascular Outcome in Hemodialysis Patients
por: Canaud, Bernard, et al.
Publicado: (2020)

Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients
por: Cekiç, Deniz, et al.
Publicado: (2023)

Effects of Proton Pump Inhibitors on Patient Survival in Patients Undergoing Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
por: Wu, Chin-Chia, et al.
Publicado: (2023)

Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients
por: Zeng, Yingsi, et al.
Publicado: (2022)

Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities
por: Canaud, Bernard, et al.
Publicado: (2019)

The Safety of Long-term Daily Usage of a Proton Pump Inhibitor: A Literature Review
por: Abbas, Mohammed K, et al.
Publicado: (2019)

Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
por: de Araújo, Lorena Maria Lima, et al.
Publicado: (2021)

Influence of Tunneled Hemodialysis-Catheters on Inflammation and Mortality in Dialyzed Patients
por: Crespo-Montero, Rodolfo, et al.
Publicado: (2021)

Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study
por: Nakashima, Akio, et al.
Publicado: (2015)

Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis
por: Okamoto, Teppei, et al.
Publicado: (2018)

The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis
por: Ramos, Rosa, et al.
Publicado: (2020)

Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2016)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Is high-volume post-dilution haemodiafiltration associated with risk of fluid volume imbalance? A national multicentre cross-sectional cohort study
por: Chazot, Charles, et al.
Publicado: (2019)

Clinical outcomes of hemodialysis patients in a public-private partnership care framework in Italy: a retrospective cohort study
por: Pedrini, L. A., et al.
Publicado: (2019)

Daily Usage of Proton Pump Inhibitors May Reduce the Severity of Critical Upper Gastrointestinal Bleeding in Elderly Patients
por: Matsuda, Hidetaka, et al.
Publicado: (2020)

Proton pump inhibitor therapy usage and associated hospitalization rates and critical care outcomes of COVID-19 patients
por: Shupp, Brittney, et al.
Publicado: (2022)

Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients
por: Zhang, Yujing, et al.
Publicado: (2022)

Measuring Mothers’ Viewpoints of Breast Pump Usage
por: Becker, Genevieve E.
Publicado: (2021)

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
por: Izquierdo, María Jesús, et al.
Publicado: (2012)

Automated individualization of dialysate sodium concentration reduces intradialytic plasma sodium changes in hemodialysis
por: Ságová, Michaela, et al.
Publicado: (2019)

Three compartment bioimpedance spectroscopy in the nutritional assessment and the outcome of patients with advanced or end stage kidney disease: What have we learned so far?
por: Broers, Natascha J. H., et al.
Publicado: (2020)

Modifiable Risk Factors Are Important Predictors of COVID-19-Related Mortality in Patients on Hemodialysis
por: Kooman, Jeroen Peter, et al.
Publicado: (2022)

Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results(1)
por: Kaysen, George A., et al.
Publicado: (2018)

Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study
por: Kruszelnicka, Olga, et al.
Publicado: (2016)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_amefv3278bkndhh6slj83ioi95